Saluvet innova INGLES
  • HOME
  • SERVICES & PRODUCTS
    • DIAGNOSTIC REAGENTS >
      • ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
      • CONTROL SERA
    • DIAGNOSTIC SERVICE >
      • BOVINE (AGENTS)
      • BOVINE (PANELS)
      • OTHER SPECIES
    • ANIMAL MODELS >
      • MODELS OF NEOSPOROSIS
      • MODELS OF TOXOPLASMOSIS
      • MODELS OF CRYPTOSPORIDIOSIS
    • DRUG SCREENING
    • TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
  • R+D+I
    • DEVELOPMENT OF VACCINES
    • DIVA VACCINES
    • IN VITRO AND IN VIVO MODELS & DRUG SCREENING
  • NEWS
  • WHO ARE WE?
  • CONTACT US
  • ESPAÑOL

DIVA VACCINES

SALUVET-innova has obtained the grant in the 2017 call of the NEOTEC program of the Technical and Industrial Development Center of the Government of Spain. The project aims to develop a serological test that will identify those vaccinated animals that are not infected from those that are infected or DIVA strategy. The technology to be developed is based on the identification of antigens associated with the infection that are differentially recognized in non-infected vaccinated animals.
Imagen
Con tecnología de Crea tu propio sitio web único con plantillas personalizables.
  • HOME
  • SERVICES & PRODUCTS
    • DIAGNOSTIC REAGENTS >
      • ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
      • CONTROL SERA
    • DIAGNOSTIC SERVICE >
      • BOVINE (AGENTS)
      • BOVINE (PANELS)
      • OTHER SPECIES
    • ANIMAL MODELS >
      • MODELS OF NEOSPOROSIS
      • MODELS OF TOXOPLASMOSIS
      • MODELS OF CRYPTOSPORIDIOSIS
    • DRUG SCREENING
    • TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
  • R+D+I
    • DEVELOPMENT OF VACCINES
    • DIVA VACCINES
    • IN VITRO AND IN VIVO MODELS & DRUG SCREENING
  • NEWS
  • WHO ARE WE?
  • CONTACT US
  • ESPAÑOL